opto biolabs GmbH announced that Photochemical Internalization (PCI) is a novel adjuvant technology.
Public source
Publisher name
Public post
Photochemical Internalization (PCI) as a novel adjuvant technology! Way to go, Pål and Team 💡 🌈 💉 #photochemistry #PDT #vaccination #immunology #cancerimmunotherapy
Company
opto biolabs GmbH
We bring the perfect light control to your cutting edge reasearch!
- Industry
- Biotechnology Research
- Location
- Freiburg, DE
- Company size
- 2–10 employees
About opto biolabs GmbH
opto biolabs develops smart illumination devices for the research areas of optogenetics and photopharmacology. Our product portfolio ranges from plate illumination devices, flow cytometry illumination devices to custom build prototypes tailored to your needs! Currently in the development pipeline: Optogenetic cell sorting allowing you to sort your cell samples according to their reactivity to light!
See moreDiscover more
Similar signals
Similar public activity from other companies.
Products & Services
emp Biotech GmbH
emp Biotech GmbH released the TurboTag™ 490 (Fluorospin) Protein Labeling and Purification Kit (#MK-D0125) for high-sensitivity fluorescence detection required for microfluidic sizing.
Products & Services
FluoSphera
FluoSphera launched a new website featuring its technology, applications, and solutions for drug discovery and preclinical studies.
Products & Services
CO.DON GmbH
CO.DON GmbH released a new company film titled 'Gelenkerhalt' showcasing the company's mission and technology.
Products & Services
Cosmo Bio USA
Cosmo Bio USA announced the release of Bio-ReCell's particle-based platforms for magnetic-bead based cell therapy activation, which remove bead removal and residual material clean-up without requiring new culture formats.
Products & Services
Sino Biological Europe